101.
Self-report compared to electronic medical record across eight adult vaccines: Do results vary by demographic factors?
by Rolnick, S.J
Vaccine, 2013, Vol.31 (37), p.3928-3935
102.
Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England
by van Hoek, Albert Jan
Vaccine, 2014, Vol.32 (34), p.4349-4355
103.
Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom
by Lau, Wallis C.Y
Vaccine, 2015, Vol.33 (39), p.5072-5079
104.
105.
Influenza vaccination of health care workers in hospitals—A review of studies on attitudes and predictors
by Hollmeyer, Helge G
Vaccine, 2009, Vol.27 (30), p.3935-3944
106.
What the World's religions teach, applied to vaccines and immune globulins
by Grabenstein, John D
Vaccine, 2013, Vol.31 (16), p.2011-2023
107.
The global impact of vaccination against hepatitis B: A historical overview
by Zanetti, Alessandro R
Vaccine, 2008, Vol.26 (49), p.6266-6273
108.
“HPV? Never heard of it!”: A systematic review of girls’ and parents’ information needs, views and preferences about human papillomavirus vaccination
by Hendry, Maggie
Vaccine, 2013, Vol.31 (45), p.5152-5167
109.
The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly
by Van Buynder, P.G
Vaccine, 2013, Vol.31 (51), p.6122-6128
110.
Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice
by Kim, Eun
Vaccine, 2014, Vol.32 (45), p.5975-5982
111.
The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns
by Wijnans, Leonoor
Vaccine, 2012, Vol.31 (8), p.1246-1254
112.
Influenza vaccine: The challenge of antigenic drift
by Carrat, F
Vaccine, 2007, Vol.25 (39), p.6852-6862
114.
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses
by Guy, Bruno
Vaccine, 2009, Vol.28 (3), p.632-649
115.
Comparison of the safety and immunogenicity of an MF59® -adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects
by Frey, Sharon E
Vaccine, 2014, Vol.32 (39), p.5027-5034
116.
Cross-sectional survey: Risk-averse French general practitioners are more favorable toward influenza vaccination
by Massin, Sophie
Vaccine, 2014, Vol.33 (5), p.610-614
117.
A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials
by Boge, Thierry
Vaccine, 2009, Vol.27 (41), p.5677-5684
118.
Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial
by Grode, Leander
Vaccine, 2012, Vol.31 (9), p.1340-1348
119.
120.
Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects
by Wigle, Jannah
Vaccine, 2013, Vol.31 (37), p.3811-3817
Filter electronic articles 8.606 Hits
Remove Filters
- Journal Title
- Vaccine
- Vaccine 26: 4494-4505 (1)
- Vaccine 23: 4342-4352 (1)
- more ...